ICH Q14 Guidelines: Fundamentals of Analytical Procedure Development
Quality Guideline
The ICHÂ (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; www.ich.org) brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development.
The ICH Q14 guideline aligns the scientific methods of Analytical Procedure Development and outlines the key principles for describing this process. Its goal is to enhance regulatory communication between industry and regulators, supporting more efficient, scientifically sound, and risk-based approval, along with effective post-approval change management of analytical procedures.
Disclaimer: The opinions shared by the presenters, panellists, and authors as part of this learning hub represent their individual interpretations of the ICH guidelines and do not embody the official positions of their respective organisations or the ICH itself.
By accessing this learning hub, you will be able to:
- Understand the objectives and development history of ICH Q14, from its inception in 2018 through to Step 4 in 2023, and how it harmonises scientific and risk-based approaches to analytical procedure development in line with ICH Q8, Q9, Q12, and Q2.
- Learn the difference between minimal and enhanced approaches to analytical procedure development, and how implementing more elements of the enhanced approach fosters deeper procedural understanding, increased lifecycle flexibility, and more suitable established conditions.
- Discover how the Analytical Target Profile (ATP) serves as the central, technology-independent performance framework connecting CQA (Critical Quality Attribute) control requirements to analytical procedure development, validation, and ongoing lifecycle management.
- Explore how established conditions and reporting categories are identified and justified through risk assessment, prior knowledge, and development data, and how the ICHQ14 framework links procedural change risk to the appropriate regulatory pathway.
Related learning hubs
- Implementing ICH Q14 Guidelines for Analytical Excellence – coming!
- ICH Q2(R2) & Q14 for Biologics: Practical Expert Insights – coming!
Brought to you by:
